{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T18:10:04Z","timestamp":1793988604019,"version":"4.8.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["E3-2022-23683266 PNC-HLS-DA"],"award-info":[{"award-number":["E3-2022-23683266 PNC-HLS-DA"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["24534"],"award-info":[{"award-number":["24534"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2022ZKKWLW"],"award-info":[{"award-number":["2022ZKKWLW"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015410","name":"Societ\u00e0 Italiana di Medicina Interna","doi-asserted-by":"publisher","award":["CAMEL"],"award-info":[{"award-number":["CAMEL"]}],"id":[{"id":"10.13039\/501100015410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"DOI":"10.1186\/s13045-025-01699-x","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T12:56:22Z","timestamp":1745412982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Spatial imaging unlocks the potential of charting multiple myeloma and extramedullary disease"],"prefix":"10.1186","volume":"18","author":[{"given":"Vanessa","family":"Desantis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Andriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"D\u00fcking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Hartwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ingravallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Biondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cirino","family":"Botta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Giovanni","family":"Solimando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"3","key":"1699_CR1","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41556-024-01358-2","volume":"26","author":"T Roider","year":"2024","unstructured":"Roider T, Baertsch MA, Fitzgerald D, V\u00f6hringer H, Brinkmann BJ, Czernilofsky F, et al. Multimodal and spatially resolved profiling identifies distinct patterns of T cell infiltration in nodal B cell lymphoma entities. Nat Cell Biol. 2024;26(3):478\u201389.","journal-title":"Nat Cell Biol"},{"issue":"10","key":"1699_CR2","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/ajh.27023","volume":"98","author":"S Zanwar","year":"2023","unstructured":"Zanwar S, Ho M, Lin Y, Kapoor P, Binder M, Buadi FK, et al. Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma. Am J Hematol. 2023;98(10):1540\u20139.","journal-title":"Am J Hematol"},{"issue":"1","key":"1699_CR3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41467-017-00296-y","volume":"8","author":"L Rasche","year":"2017","unstructured":"Rasche L, Chavan SS, Stephens OW, Patel PH, Tytarenko R, Ashby C, et al. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing. Nat Commun. 2017;8(1):268.","journal-title":"Nat Commun"},{"issue":"15","key":"1699_CR4","doi-asserted-by":"publisher","first-page":"e167629","DOI":"10.1172\/JCI167629","volume":"133","author":"MH Robinson","year":"2023","unstructured":"Robinson MH, Villa NY, Jaye DL, Nooka AK, Duffy A, McCachren SS, et al. Regulation of antigen-specific T cell infiltration and Spatial architecture in multiple myeloma and premalignancy. J Clin Invest. 2023;133(15):e167629.","journal-title":"J Clin Invest"},{"issue":"3","key":"1699_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1158\/0008-5472.CAN-22-2654","volume":"84","author":"YB Hagos","year":"2024","unstructured":"Hagos YB, Lecat CSY, Patel D, Mikolajczak A, Castillo SP, Lyon EJ, et al. Deep learning enables Spatial mapping of the mosaic microenvironment of myeloma bone marrow Trephine biopsies. Cancer Res. 2024;84(3):493\u2013508.","journal-title":"Cancer Res"},{"issue":"20","key":"1699_CR6","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1182\/blood.2024024590","volume":"144","author":"M John","year":"2024","unstructured":"John M, Helal M, Duell J, Mattavelli G, Stanojkovska E, Afrin N, et al. Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma. Blood. 2024;144(20):2121\u201335.","journal-title":"Blood"},{"issue":"9","key":"1699_CR7","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1038\/s41375-023-01983-0","volume":"37","author":"D Chemlal","year":"2023","unstructured":"Chemlal D, Varlet E, Machura A, Ovejero S, Requirand G, Robert N, et al. EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma. Leukemia. 2023;37(9):1925\u20138.","journal-title":"Leukemia"},{"issue":"12","key":"1699_CR8","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/S1470-2045(20)30525-8","volume":"21","author":"SK Kumar","year":"2020","unstructured":"Kumar SK, Harrison SJ, Cavo M, De La Rubia J, Popat R, Gasparetto C, et al. Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial. Lancet Oncol. 2020;21(12):1630\u201342.","journal-title":"Lancet Oncol"},{"key":"1699_CR9","doi-asserted-by":"crossref","unstructured":"Notarfranchi L, Accardi F, Mancini C, Martella E, Bonomini S, Segreto R et al. CD38 expression by plasma cells In extramedullary multiple myeloma. Haematologica [Internet]. 2023 Nov 9 [cited 2024 Dec 9]; Available from: https:\/\/haematologica.org\/article\/view\/haematol.2023.284169","DOI":"10.3324\/haematol.2023.284169"},{"issue":"7","key":"1699_CR10","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.3390\/curroncol30070455","volume":"30","author":"E Cencini","year":"2023","unstructured":"Cencini E, Sicuranza A, Ciofini S, Fabbri A, Bocchia M, Gozzetti A. Tumor-Associated macrophages in multiple myeloma: key role in disease biology and potential therapeutic implications. Curr Oncol. 2023;30(7):6111\u201333.","journal-title":"Curr Oncol"},{"issue":"24","key":"1699_CR11","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1056\/NEJMoa2204591","volume":"387","author":"A Chari","year":"2022","unstructured":"Chari A, Minnema MC, Berdeja JG, Oriol A, Van De Donk NWCJ, Rodr\u00edguez-Otero P, et al. Talquetamab, a T-Cell\u2013Redirecting GPRC5D bispecific antibody for multiple myeloma. N Engl J Med. 2022;387(24):2232\u201344.","journal-title":"N Engl J Med"},{"issue":"1","key":"1699_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13045-024-01555-4","volume":"17","author":"S Zanwar","year":"2024","unstructured":"Zanwar S, Sidana S, Shune L, Puglianini OC, Pasvolsky O, Gonzalez R, et al. Impact of extramedullary multiple myeloma on outcomes with Idecabtagene vicleucel. J Hematol OncolJ Hematol Oncol. 2024;17(1):42.","journal-title":"J Hematol OncolJ Hematol Oncol"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-025-01699-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-025-01699-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-025-01699-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T12:56:24Z","timestamp":1745412984000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-025-01699-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1699"],"URL":"https:\/\/doi.org\/10.1186\/s13045-025-01699-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5402785\/v1","asserted-by":"object"}]},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the University of Bari Medical School (Study No. 7411, Protocol No. 0073322, approved on 26\/08\/2022 and Study No. 1879, Protocol No. 808 approved on 02\/10\/2024). All procedures involving human participants were conducted following the ethical standards outlined in the Declaration of Helsinki. Written informed consent was obtained from all enrolled patients before they participated in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided written informed consent for the publication of anonymized data derived from this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A.G.S. has received speaker honorariums from Sanofi, Amgen, and AstraZeneca. He has also participated on advisory boards for Pfizer and Menarini. He received travel support for educational purposes from Janssen Cilag. C.B. has served as a speaker or consultant for Amgen, Janssen Cilag, Pfizer, Sanofi Aventis, Takeda, GSK, Oncopeptides. A.V. received speaker honorariums from Pfizer, Sanofi, Bristol Myers Squibb, Takeda, Janssen Cilag, AstraZeneca, Menarini, and Amgen. R.R. has served as a speaker or consultant for Amgen, BMS-Celgene, CSL Behring, Janssen Cilag, Octapharma, Pfizer, Sanofi, Takeda. These potential conflicts of interest do not imply bias or influence on the authors\u2019 opinions or actions. The authors are aware of the importance of transparency in the scientific field and are committed to defending their integrity and the trust in them within the scientific community.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}